Skip to content
The Yangtzeer

The Yangtzeer

Covering the people, capital and innovation shaping the Yangtze River Delta

  • Home
  • News
    • Deals
    • Heavy Hitters
    • Startups
    • Policy
    • Research
  • Feature
    • Industry Pulse
    • Unicorn Club
    • Cluster Spotlight
    • Policy Decoded
  • Opinion
    • Editor’s View
    • Guest Posts
  • People
    • Old Guard
    • New Wave
    • Capital Journal
  • About
  • Contact
  • Home
  • cannabinoid

Tag: cannabinoid

  • News
  • Research

Zhejiang University study finds path to non-addictive pain relief drug

admin2026-04-142026-04-1403 mins

Cannabinoid compounds are known to be effective in treating conditions such as chronic pain, anxiety and epilepsy, but their clinical use has been constrained by risks of addiction and other side effects.

Read More

Recent News

  • Hangzhou BMS leader Gold Electronic soars 625% in ChiNext debut
  • Hangzhou debuts 9-level AI skills ranking system for one-person companies
  • Suzhou Industrial Park listed firms hit $177 billion in market value
  • China’s first ultralight aircraft insurance policy targets safety gap
  • Chint deepens Alibaba Cloud partnership to embed AI across operations

Archives

  • June 2026
  • May 2026
  • April 2026
  • March 2026
June 2026
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
« May    
Copyright © 2026 The Yangtzeer. All rights reserved. Powered By BlazeThemes.